Exact Sciences surged more than 17% premarket after Abbott announced a $23 billion buyout, adding Cologuard and Oncotype DX ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback